Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,332 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tunable antibodies.
Weiner LM, Carter P. Weiner LM, et al. Among authors: carter p. Nat Biotechnol. 2005 May;23(5):556-7. doi: 10.1038/nbt0505-556. Nat Biotechnol. 2005. PMID: 15877072 No abstract available.
The rollercoaster ride to anti-cancer antibodies.
Weiner LM, Carter P. Weiner LM, et al. Among authors: carter p. Nat Biotechnol. 2003 May;21(5):510-1. doi: 10.1038/nbt0503-510. Nat Biotechnol. 2003. PMID: 12721576 No abstract available.
An efficient route to human bispecific IgG.
Merchant AM, Zhu Z, Yuan JQ, Goddard A, Adams CW, Presta LG, Carter P. Merchant AM, et al. Among authors: carter p. Nat Biotechnol. 1998 Jul;16(7):677-81. doi: 10.1038/nbt0798-677. Nat Biotechnol. 1998. PMID: 9661204
Binders from the deepest vaults.
Carter P. Carter P. Nat Biotechnol. 1996 Mar;14(3):267. doi: 10.1038/nbt0396-267. Nat Biotechnol. 1996. PMID: 9630883 No abstract available.
More reflection, less written ?
Carter P. Carter P. Educ Prim Care. 2022 Jun 29:1. doi: 10.1080/14739879.2022.2090284. Online ahead of print. Educ Prim Care. 2022. PMID: 35770331 No abstract available.
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.
Berlak M, Tucker E, Dorel M, Winkler A, McGearey A, Rodriguez-Fos E, da Costa BM, Barker K, Fyle E, Calton E, Eising S, Ober K, Hughes D, Koutroumanidou E, Carter P, Stankunaite R, Proszek P, Jain N, Rosswog C, Dorado-Garcia H, Molenaar JJ, Hubank M, Barone G, Anderson J, Lang P, Deubzer HE, Künkele A, Fischer M, Eggert A, Kloft C, Henssen AG, Boettcher M, Hertwig F, Blüthgen N, Chesler L, Schulte JH. Berlak M, et al. Among authors: carter p. Mol Cancer. 2022 Jun 10;21(1):126. doi: 10.1186/s12943-022-01583-z. Mol Cancer. 2022. PMID: 35689207 Free PMC article.
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8).
Sreekantha RK, Mussari CP, Dodd DS, Pasunoori L, Hegde S, Posy SL, Critton D, Ruepp S, Subramanian M, Salter-Cid LM, Tagore DM, Sarodaya S, Dudhgaonkar S, Poss MA, Schieven GL, Carter PH, Macor JE, Dyckman AJ. Sreekantha RK, et al. Among authors: carter ph. ACS Med Chem Lett. 2022 Apr 25;13(5):812-818. doi: 10.1021/acsmedchemlett.2c00049. eCollection 2022 May 12. ACS Med Chem Lett. 2022. PMID: 35586440
1,332 results